Home » Topics » BioWorld Science

BioWorld Science
RSS

Teneobio and Poseida to use UniDabs to develop CAR-T therapies

Aug. 8, 2018

Aged rhesus monkey shows same pattern of tau pathology as humans

Aug. 8, 2018

New sulfonamide is potent anti-breast cancer agent

Aug. 8, 2018

Recruitment underway in TaiRx's phase II study of CMV-118 in combination with sorafenib

Aug. 8, 2018

DMC recommends early continuation of phase III GENESIS study of BL-8040

Aug. 8, 2018

ADC Therapeutics begins dosing in registrational phase II trial evaluating ADCT-402

Aug. 8, 2018

Researchers present new anti-CRH MAb for AD downstream pathologies

Aug. 8, 2018

FDA expands approval of Orkambi to children 2 to 5 years of age

Aug. 8, 2018

Plant-derived compound silvestrol inhibits HEV replication with additive effect to ribavirin

Aug. 8, 2018

Neuroendocrine stress pathways mediate the adverse health effects of air pollution

Aug. 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...